Join Richard A. Smith, MD, Center for Neurologic Study, La Jolla, California, as he discusses "Neurotherapeutics in the Era of Translational Medicine."

During his neurology residency at Stanford University, Dr. Smith began his first studies of Lou Gehrig's Disease which has remained his principal career interest. His initial studies focused on the symptomatic treatment of ALS but at Scripp's Research Institute, he began to research the cause of ALS and subsequently directed his major effort to developing a therapy for ALS and kindred disorders.